Tierexperimentelle Untersuchungen zur parenteralen Verwertung von Maltose
- 1 September 1976
- journal article
- abstracts
- Published by Springer Nature in Zeitschrift Fur Ernahrungswissenschaft
- Vol. 15 (3) , 270-283
- https://doi.org/10.1007/bf02022004
Abstract
The utilisation of parenterally administered maltose was investigated in the anaesthetized rat, and in rats fixed in metabolic cages. Additionally, the metabolism of maltose was measured with the isolated perfused rat liver. During intravenous infusion of 0.3 g, 0.6 g or 1.2 g maltose (corresponding to 0.9 g, 1.8 g or 3.6 g/kg bodyweight) per hour a steady-state for maltose in blood was attained. Blood glucose concentration rose during the maltose infusions. The utilisation of parenterally administered maltose was established by a high rate of glycogen storage in the liver and by a decrease in concentration of free fatty acids in serum. During the 72 hour infusion of maltose at a rate of 0.23 g/hour (corresponding to 0.70 g/kg bodyweight) a constant blood maltose concentration of 60 mg/100 ml was measured. Simultaneously, the blood glucose concentration increased. The excretion of maltose and of glucose was approximately 5% of the total amount administered intravenously. The nitrogen sparing effect of maltose was equal to that of glucose (or glucose substitutes). In the streptozotocindiabetic rats, the renal excretion of maltose and glucose was 20-30% of the total amount. Moreover, blood glucose concentration was elevated significantly during maltose infusion. In the isolated perfused rat liver maltose hydrolysis was established. However, the glucose obtained by this hydrolysis was not metabolized by the isolated organ as was observed for glucose. On the other hand, the glucose substitutes (fructose, xylitol, sorbitol) are also partially transformed to glucose by the isolated liver. These substances, however, were additionally utilized by this organ in other ways. On the basis of these results it is concluded that maltose is metabolized following its intravenous application. Therefore, maltose should have advantages compared to glucose because of the lower osmotic pressure. The metabolism of maltose, however, is similar to that of glucose. The advantages of the glucose substitutes (fructose, sorbitol, xylitol) are not shared by maltose.Keywords
This publication has 13 references indexed in Scilit:
- The Suitability of Maltose for Parenteral NutrionIntensive Care Medicine, 1975
- Stoffwechseluntersuchungen während und im Anschluß an Dauerinfusionen von Glucose und von ZuckeraustauschstoffenDeutsche Medizinische Wochenschrift (1946), 1974
- [Biochemical considerations of the use of carbohydrates in parenteral feeding].1974
- The Metabolism of Maltose After Intravenous Injection in Normal and Diabetic SubjectsJournal of Clinical Endocrinology & Metabolism, 1974
- Distribution of Maltose Intravenously Administered to Rabbits and Its Metabolism in the KidneyThe Tohoku Journal of Experimental Medicine, 1974
- The metabolism of circulating maltose in manJournal of Clinical Investigation, 1971
- Metabolism of Circulating Disaccharides in Man and the Rat *Journal of Clinical Investigation, 1967
- Metabolism of uniformly labeled [14C] maltotriose in the ratBiochimica et Biophysica Acta (BBA) - General Subjects, 1967
- The Digestion and Absorption of Maltose and Trehalose by the Intact RatActa Physiologica Scandinavica, 1963
- α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease)Biochemical Journal, 1963